This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aguero, M. F. Articles by Senderowicz, A. M. Search for Related Content PubMed PubMed Citation Articles by Aguero, M. F. Articles by Senderowicz, A. M.

Phenoxodiol, a Novel Isoflavone, Induces G₁ Arrest by Specific Loss in Cyclin-Dependent Kinase 2 Activity by p53-Independent Induction of p21^WAF1/CIP1

Molecular Therapeutics Unit, Oral & Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland

Requests for reprints: Adrian M. Senderowicz, Molecular Therapeutics Unit, Oral & Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, NIH, Building 30, Room 212, Bethesda, MD 20892-4330. Phone: 301-594-5270; Fax: 301-402-0823; E-mail: adrian.senderowicz{at}nih.gov.

Phenoxodiol, an isoflavone derivative of genistein with unknown mechanism of action, is currently being evaluated in early human cancer clinical trials. To determine the mechanism of antiproliferative effects of phenoxodiol, we examined its effects in a battery of human cell lines. Although we observed caspase-dependent apoptosis in HN12 cells as early as 24 hours after exposure, clonogenic death occurred only after 48-hour exposure despite caspase blockade by the general caspase inhibitor, benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone (ZVAD)-fmk. Moreover, clear evidence of cell death as determined by nuclear morphology and plasmatic membrane damage occur despite ZVAD, suggesting that another mechanism besides caspase-dependent apoptosis is required for clonogenic death induced by phenoxodiol. In search for other potential antiproliferative effects, we assessed the effects of phenoxodiol in the cell cycle progression of human carcinoma cell lines. A significant G₁-S arrest was observed by 12 hours of exposure in HN12 cell lines at concentrations 5 µg/mL. Cell cycle arrest occurred several hours (12 hours) before induction of apoptosis. Analysis of in vitro purified cyclin-dependent kinase (cdk) activity showed that phenoxodiol did not inhibit cdk activity. In contrast, cellular cdk2 activity obtained from HN12 cell lines exposed to phenoxodiol for 12 hours decreased by 60%, whereas cdk6 activity remained unaltered, suggesting that the loss of cdk2 activity was specific. Loss in cdk2 activity was preceded by the accumulation of the endogenous cdk inhibitor p21^WAF1. To assess the role of p21^WAF1 induction by phenoxodiol, we used HCT116 isogenic cell lines and showed that phenoxodiol induced G₁ arrest together with p21^WAF1 expression in wild-type clones. In contrast, p21^–/– variants failed to show G₁ arrest. Finally, induction of p21 by phenoxodiol is p53 independent, as phenoxodiol induced p21 in HCT116 lacking p53. These data therefore indicate that phenoxodiol promotes G₁-S arrest by the specific loss in cdk2 activity due to p53-independent p21^WAF1 induction. This novel feature of phenoxodiol may have clinical implications, as the majority of human malignancies have aberrations in cell cycle progression regulation.

This article has been cited by other articles:

				P. M. Herst, J. E. Davis, P. Neeson, M. V. Berridge, and D. S. Ritchie The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells Haematologica, July 1, 2009; 94(7): 928 - 934. [Abstract] [Full Text] [PDF]

				T. Lotan, J. Hickson, J. Souris, D. Huo, J. Taylor, T. Li, K. Otto, S. D. Yamada, K. Macleod, and C. W. Rinker-Schaeffer c-Jun NH2-Terminal Kinase Activating Kinase 1/Mitogen-Activated Protein Kinase Kinase 4-Mediated Inhibition of SKOV3ip.1 Ovarian Cancer Metastasis Involves Growth Arrest and p21 Up-regulation Cancer Res., April 1, 2008; 68(7): 2166 - 2175. [Abstract] [Full Text] [PDF]

				S. Roy, M. Kaur, C. Agarwal, M. Tecklenburg, R. A. Sclafani, and R. Agarwal p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells Mol. Cancer Ther., October 1, 2007; 6(10): 2696 - 2707. [Abstract] [Full Text] [PDF]

				Y. Ueno, C. Kitamura, M. Terashita, and T. Nishihara Re-oxygenation Improves Hypoxia-induced Pulp Cell Arrest Journal of Dental Research, September 1, 2006; 85(9): 824 - 828. [Abstract] [Full Text] [PDF]

				J. M.R. Patlolla, J. Raju, M. V. Swamy, and C. V. Rao {beta}-Escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21waf1/cip1 in colon cancer cells. Mol. Cancer Ther., June 1, 2006; 5(6): 1459 - 1466. [Abstract] [Full Text] [PDF]

				H. Zhu and N. J. Gooderham Mechanisms of Induction of Cell Cycle Arrest and Cell Death by Cryptolepine in Human Lung Adenocarcinoma A549 Cells Toxicol. Sci., May 1, 2006; 91(1): 132 - 139. [Abstract] [Full Text] [PDF]